DODGE & COX 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 1:21 pm Sale |
2023-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
DODGE & COX | 13,994,063 7.400% |
-389,600 (-2.71%) |
Filing |
| 2023-02-14 1:25 pm Sale |
2022-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
DODGE & COX | 14,383,663 7.700% |
-441,386 (-2.98%) |
Filing |
| 2022-02-14 12:48 pm Purchase |
2021-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
DODGE & COX | 14,825,049 8.100% |
5,028,125 (+51.32%) |
Filing |
| 2021-02-11 3:42 pm Purchase |
2020-12-31 | 13G | BioMarin Pharmaceutical Inc. BMRN |
DODGE & COX | 9,796,924 5.400% |
9,796,924 (New Position) |
Filing |